O28.2
Abnormal cytological finding on antenatal screening of mother
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code O28.2 refers to an abnormal cytological finding identified during antenatal screening of a pregnant woman. Cytological tests, such as Pap smears, are used to detect changes in cervical cells that might indicate infections, pre-cancerous conditions, or other cellular abnormalities. Identifying these abnormalities early helps guide further diagnostic assessments and management to ensure the health and safety of both mother and baby during pregnancy.
Causes & Symptoms
Clinical Causes: Infections, such as human papillomavirus (HPV) Hormonal changes during pregnancy affecting cervical cells Persistent inflammation or cervicitis Pre-cancerous cellular alterations (dysplasia) Previous history of cervical abnormalities or treatments Other underlying gynecological conditions
Key Symptoms: Typically, no symptoms are present Abnormal vaginal discharge Spotting or irregular bleeding Possible discomfort or pain in the pelvic area Unusual odor from vaginal discharge
Diagnostic & Treatment
Diagnosis Path: Diagnosis often begins with a routine Pap smear or cervical cytology test, which examines cell samples collected from the cervix. If abnormalities are detected, further assessments such as colposcopy, HPV testing, or biopsy may be recommended to evaluate the extent and nature of the cellular changes. These diagnostic procedures help determine whether the abnormal findings are benign or indicative of pre-cancerous changes requiring intervention.
Treatment Protocols: Treatment depends on the type and severity of the abnormal cytological finding. Possible options include:
Clinical Advice & FAQs
Billing Guidance
Is O28.2 a billable ICD-10 code?
Yes, O28.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O28.2?
Clinical documentation must specify the nature of Abnormal cytological finding on antenatal screening of mother and any associated comorbidities for accurate reporting.
Cite this Clinical Reference